• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

  • Sort by Name
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Click to order products ascending
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...
    Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in ‘Theranostics’ and Personalized Medicine)

    Published: June 1, 2008 | Price: $2,995.00 – $5,990.00

    This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as a pathway to personalized medicine, where the right therapeutic is...
    Companion Diagnostics Markets: Forecasts to 2018 (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

    Published: August 8, 2014 | Price: $995.00 – $1,990.00

    Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others) Companion drug/test products are of great interest to pharmaceutical companies, testmakers, as well as investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment. This report explains events in the market and provides lists of companion products. It also...
    Complex Regional Pain Syndrome (CRPS) – A Market Briefing

    Published: August 1, 2005 | Price: $795.00 – $1,990.00

    Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection. On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as...
    Computed Tomography (CT) Markets

    Published: January 5, 2017 | Price: $3,600.00 – $7,200.00

    Computed Tomography (CT) Markets Computed Tomography (CT) Markets focuses on the worldwide opportunity for computed tomography, including data on global revenue for medical CT systems, 2016-2021; major competitors’ percentage share of the global revenue for medical CT systems, 2016; global revenue geographic share for medical CT systems, 2016 (US, Europe, China, Brazil, Asia Pacific [APAC], ROW); and future CT regional revenue growth trends. The report outlines trends, challenges and issues, and major developments in this modality’s market. Analogic, Arineta, Bayer,...
    Computer-Assisted Surgical Systems: A Market Briefing

    Published: February 1, 2005 | Price: $995.00 – $1,990.00

    Computer-based technologies offer significant potential for improving the clinical outcomes of patients. Computer software and hardware, as well as the systems they control, have begun to impact the manner in which surgeons design, plan, simulate and perform surgery. In the last few years, automated and computer-assisted techniques have found increased use in surgical procedures as tools for performing difficult neurosurgery, cranio-facial surgery and some orthopedic procedures. These techniques give the surgeon more advanced capabilities than were available previously, such as...
    Congestive Heart Failure – Major World Markets, Volume I – Pharmaceutical Management

    Published: February 1, 2008 | Price: $895.00 – $6,990.00

    Congestive heart failure is an increasingly important cause of cardiovascular morbidity and mortality. It is the number one cause of hospitalization among individuals aged 65 and over. The United States Medicare system pays out more for the care of congestive heart failure than it does for all forms of cancer combined. While this is a challenge for the US healthcare system, it indicates a strong market opportunity for pharmaceutical companies involved in CHF treatment. Kalorama Information's Congestive Heart Failure, Major...
    Congestive Heart Failure – Major World Markets, Volume II – Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

    Published: February 1, 2008 | Price: $995.00 – $1,990.00

    Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy, which is the final common pathway for many cardiac illnesses and a common cause of congestive heart failure. Kalorama Information's Congestive Heart Failure, Major World Markets series looks at markets for...
    Consumer Testing and The Future of DTC Genetic Testing

    Published: June 1, 2012 | Price: $495.00 – $990.00

    In February and March of 2012, Kalorama Information conducted a survey of 2,000 adults to ask them whether or not they would take a genetic test.   This report, Consumer Testing and the Future of DTC Genetic Testing provides those results and compiles surveys from public and private sources to provide the following insights:   Have Consumers Used a Self-Test Product? Would They Take a Genetic Test? Are They Concerned About Their Healthcare? What Diseases Are They Most Concerned About?...
    Contract Manufacturing in Medical Devices (Materials, Processing, Electronics, Finished Products)

    Published: April 1, 2011 | Price: $150.00 – $300.00

    Medical device manufacturers are under pressure to reduce costs and improve margins and outsourcing at least some operations is increasingly a tactic for the top original equipment manufacturers (OEMs). There are hundreds of firms who specialize in device making operations and many more companies that do some medical device work. Kalorama's Contract Manufacturing in Medical Devices (Materials, Processing, Electronics, Finished Products) is a complete study of the market and opportunity for outsourcing finished medical devices or a part of a...
    Contract Manufacturing in Medical Devices (Raw Materials, Electronics and Finished Products Markets)

    Published: November 1, 2007 | Price: $3,800.00 – $13,990.00

    The trend of medical device outsourcing, or contract manufacturing is increasing. This Kalorama Information report takes an exhaustive look at the total market of OEMs outsourcing device manufacture to CMs. This publication represents the total OEM contract manufacturing market - it is the combination of three volumes in Kalorama Information's OEM Contract Manufacturing in Medical Devices Series. (The publication is combined for PDF delivery and hard copy delivery would come in three seperate volumes) For electronic delivery, a special overview...
    Contract Manufacturing in Orthopedics Devices: Markets for Hip and Knee Implants

    Published: February 1, 2009 | Price: $995.00 – $3,000.00

    This Kalorama report, Contract Manufacturing in Orthopedics Devices: Markets for Hip and Knee Implants provides market size and forecast for the most utilized orthopedic devices. A global report, the business is calculated and forecasted for the United States, Europe, Asia and Rest of World. This report should be of interest to both the established and new entrant CM’s that are engaged in customer retention with existing revenues and established business, or generating new revenue streams from the high growth medical...
    Contract Manufacturing in Syringes, Catheters, Hip and Knee Implants, Air Pathways and other High Growth Markets

    Published: September 1, 2008 | Price: $2,250.00 – $5,500.00

    Contract Manufacturers seeking to partner with global marketers can find the best opportunities making the medical devices that drive the best sales and growth for global marketers. This report covers contract manufacturing (CM) in several medical devices that show promising growth for the next five years. The report details the following areas and provides forecasts for the next five years:   Cardiac Pace Makers Implantable Defibrillators Catheters Syringes Orthopedic Hip Implants Orthopedic Knee Implants Oxygen Concentrators (Standard and Portable) Continuous...
    Contract Manufacturing of Medical Devices in China

    Published: November 1, 2016 | Price: $2,000.00 – $4,000.00

    Contract Manufacturing of Medical Devices in China This report looks at trends in the manufacturing of medical devices by contracted or outsourced companies for major device maufacturers. As part of its research the reprot includes market forecasts, lists of companies and other important business information. The market analysis in the report contains several segments based on processes withing outsroucing such as electronic parts, finished products or materials as well as clinical area breakouts.
    Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures, 2002-2006

    Published: October 1, 2004 | Price: $395.00 – $790.00

    Based on findings from Kalorama Information’s research study Facial Cosmetic Surgery and Rejuvenation Markets: Business, Technologies, and Competitive Intelligence (July 2004), this summary covers the top five surgeries and an “other” category. The top five procedures are: Breast augmentation/reduction Liposuction Rytidectomy (face lifts) Blepharoplasty (eyelid lift) Rhinoplasty (nose job) The analysis includes data on procedures and revenues for surgery but not market data for conventional surgical instruments and equipment. The “other” category includes such procedures as tummy tucks , buttocks...
Page 8 of 59«‹678910›»

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top